Academic Journal
Building a National Infection Prevention and Control Programme: the 'Turn Nigeria Orange' Programme, 2019-2023.
| Τίτλος: | Building a National Infection Prevention and Control Programme: the 'Turn Nigeria Orange' Programme, 2019-2023. |
|---|---|
| Συγγραφείς: | Okwor T; Disease Prevention and Health Promotion, Nigeria Centre for Disease Control and Prevention, Jabi, Abuja, Nigeria tochi.okwor@ncdc.gov.ng., Tompkins LK; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA., Gadanya M; Disease Prevention and Health Promotion, Nigeria Centre for Disease Control and Prevention, Jabi, Abuja, Nigeria., Leighty E; CDC Foundation, Atlanta, Georgia, USA., Okoro BC; Disease Prevention and Health Promotion, Nigeria Centre for Disease Control and Prevention, Jabi, Abuja, Nigeria., Idris O; Nigeria Centre for Disease Control and Prevention, Jabi, Abuja, Nigeria., Malpiedi P; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA., Ogunsola F; University of Lagos, Akoka, Nigeria. |
| Πηγή: | BMJ global health [BMJ Glob Health] 2026 May 17; Vol. 11 (5). Date of Electronic Publication: 2026 May 17. |
| Τύπος έκδοσης: | Journal Article |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101685275 Publication Model: Electronic Cited Medium: Print ISSN: 2059-7908 (Print) Linking ISSN: 20597908 NLM ISO Abbreviation: BMJ Glob Health Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: [London] : BMJ Publishing Group Ltd, [2016]- |
| Ιατρικοί όροι (MeSH): | Infection Control*/organization & administration , Cross Infection*/prevention & control , Program Development*, Nigeria ; Humans |
| Περίληψη: | Strong infection prevention and control (IPC) programmes are critical to reducing the burden of healthcare-associated infections and antimicrobial resistance (AMR), yet many low- and middle-income countries (LMICs) lack functional IPC programmes at national and health facility levels. Nigeria prioritised the development of a national programme to provide leadership and coordination for IPC activities throughout the country's healthcare system following a series of outbreaks and gaps identified during the development of the National Action Plan for AMR. We aim to describe the stepwise, evidence-based approach we used to establish and implement Nigeria's National IPC Programme during its first 5 years. This includes the formation and structure of the IPC Programme within the Nigeria Centre for Disease Control and Prevention; assessment of national and tertiary health facility-level IPC programmes to prioritise interventions; development of a structured implementation strategy (the 'Turn Nigeria Orange' programme); publication of national IPC guidelines and revision of the national IPC policy; collaboration with a local university and professional societies to establish a national IPC curriculum and IPC training and mentorship programmes; and establishment of a network of health facilities to strengthen facility-level implementation (the 'Orange Network'). The development of each was guided by the WHO's core components of IPC programmes, evidence-based guidelines which aim to inform the development of effective IPC programmes. The implementation approaches, successes and challenges that we share add to the limited existing literature and can serve as a practical example for other countries, particularly LMICs when establishing and implementing IPC programmes. (© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.) |
| Competing Interests: | Competing interests: None declared. |
| Contributed Indexing: | Keywords: Africa; Health policies and all other topics; Health systems; Hygiene; Prevention strategies |
| Entry Date(s): | Date Created: 20260517 Date Completed: 20260716 Latest Revision: 20260804 |
| Update Code: | 20260804 |
| PubMed Central ID: | PMC13182483 |
| DOI: | 10.1136/bmjgh-2025-020879 |
| PMID: | 42144249 |
| Βάση Δεδομένων: | MEDLINE |
| ISSN: | 2059-7908 |
|---|---|
| DOI: | 10.1136/bmjgh-2025-020879 |